The Royal Childrens Hospital
Welcome,         Profile    Billing    Logout  
 0 Trials 
4 Trials

   

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
Conyers, Rachel
ALLELE, NCT03394365 / 2017-002949-30: Tabelecleucel for Solid Organ or Allogeneic Hematopoietic Cell Transplant Participants With Epstein-Barr Virus-Associated Post-Transplant Lymphoproliferative Disease (EBV+ PTLD) After Failure of Rituximab or Rituximab and Chemotherapy

Checkmark Data from ALLELE trial for post-transplant lymphoproliferative disease
Dec 2021 - Dec 2021: Data from ALLELE trial for post-transplant lymphoproliferative disease
Recruiting
3
66
Europe, Canada, US, RoW
tabelecleucel, tab-cel®, ATA129, EBV-CTL
Atara Biotherapeutics
Epstein-Barr Virus+ Associated Post-transplant Lymphoproliferative Disease (EBV+ PTLD), Solid Organ Transplant Complications, Lymphoproliferative Disorders, Allogeneic Hematopoietic Cell Transplant, Stem Cell Transplant Complications
08/25
06/27
BRUNO-PIC, NCT06529536: Utilising Genotype Informed Bayesian Dosing of Tacrolimus in Children Post Solid Organ Transplantation.

Recruiting
2
45
RoW
Genotyping for CYP3A4 and CYP3A5 genes, Use of NextDose platform, Tacrolimus, Prograf (Brand)
Murdoch Childrens Research Institute
Solid Organ Transplant
08/27
08/27
PEGASUS, NCT06383338: A Study Investigating the Change in Metabolism Phenotype in Paediatric, Adolescent & Young Adults With Hodgkin or Non-Hodgkin Lymphoma.

Not yet recruiting
1
10
RoW
Omeprazole, Dextromethorphan
Murdoch Childrens Research Institute
Hodgkin Lymphoma, Non Hodgkin Lymphoma
03/26
03/26
RAG1-SCID, NCT04797260: Phase I/II Clinical Trial Stem Cell Gene Therapy in RAG1-Deficient SCID

Recruiting
N/A
10
Europe, RoW
Gene therapy
Leiden University Medical Center, ZonMw: The Netherlands Organisation for Health Research and Development, Horizon 2020 - European Commission
Severe Combined Immunodeficiency Due to RAG1 Deficiency
12/29
12/29

Download Options